February is National Heart Health Month and Massachusetts-based Abiomed is transforming the lives of tens of thousands of patients in the U.S. and around the world with its breakthrough technology: the world’s smallest heart pump, called the Impella.
Smaller than the width of a pencil, the Impella can be inserted through the leg and assists the pumping function of the heart during cardiac procedures so that it can rest and recover. Abiomed is the only company with FDA approval for heart recovery – helping some patients heal their hearts and avoid the need for a transplant.
Abiomed is also one of the fastest growing medical device companies in the world and is proud to call Massachusetts home. Last year, the company completed a major 120,000 square foot expansion of its global headquarters in Danvers, Massachusetts. The new space doubles the size of its global headquarters and provides additional research and manufacturing capabilities, as well as the new Heart Recovery Institute for clinical education. Abiomed is bringing physicians from around the world and U.S. to train in the new field of heart recovery.
Abiomed has supported more than 65,000 patients in the U.S. with the Impella® platform, which is FDA approved as safe and effective to treat patients in cardiogenic, right side heart failure, or during high-risk procedures.
Throughout the month, Abiomed will be hosting Heart Recovery Reunions across the U.S., which are events that bring together patients with the physicians, nurses, and hospital staff who treated them and contributed to their heart recovery.
Stay tuned later this month for more updates on Abiomed!